United Capital Financial Advisors LLC Sells 385 Shares of The Cigna Group (NYSE:CI)

United Capital Financial Advisors LLC decreased its holdings in The Cigna Group (NYSE:CI) by 2.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,751 shares of the health services provider’s stock after selling 385 shares during the period. United Capital Financial Advisors LLC’s holdings in The Cigna Group were worth $3,521,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Gamco Investors INC. ET AL grew its position in shares of The Cigna Group by 0.5% during the fourth quarter. Gamco Investors INC. ET AL now owns 15,726 shares of the health services provider’s stock valued at $4,343,000 after purchasing an additional 74 shares in the last quarter. Anchor Investment Management LLC grew its holdings in The Cigna Group by 31.6% during the 4th quarter. Anchor Investment Management LLC now owns 4,317 shares of the health services provider’s stock valued at $1,192,000 after buying an additional 1,036 shares in the last quarter. Adams Wealth Management increased its stake in The Cigna Group by 28.2% in the 4th quarter. Adams Wealth Management now owns 10,003 shares of the health services provider’s stock worth $2,762,000 after acquiring an additional 2,200 shares during the last quarter. Bridgewater Associates LP raised its holdings in shares of The Cigna Group by 78.9% during the 4th quarter. Bridgewater Associates LP now owns 579,482 shares of the health services provider’s stock worth $160,018,000 after acquiring an additional 255,646 shares in the last quarter. Finally, Rossby Financial LCC bought a new position in shares of The Cigna Group during the 4th quarter valued at approximately $211,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at The Cigna Group

In other news, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the transaction, the insider now owns 29,421 shares of the company’s stock, valued at $9,065,198.52. The trade was a 14.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David Cordani sold 26,527 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now directly owns 127,767 shares of the company’s stock, valued at $39,367,568.04. The trade was a 17.19 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,751 shares of company stock valued at $13,603,991 over the last ninety days. 0.70% of the stock is owned by company insiders.

The Cigna Group Trading Up 0.2 %

Shares of NYSE CI opened at $329.97 on Friday. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The firm has a market cap of $90.30 billion, a PE ratio of 26.96, a price-to-earnings-growth ratio of 0.98 and a beta of 0.51. The business has a fifty day simple moving average of $315.18 and a two-hundred day simple moving average of $311.07. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the prior year, the company earned $6.79 earnings per share. Analysts expect that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th were paid a dividend of $1.51 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.83%. The Cigna Group’s dividend payout ratio (DPR) is currently 49.35%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Sanford C. Bernstein downgraded shares of The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target on the stock. in a research note on Thursday, February 6th. Morgan Stanley lowered their price target on shares of The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Stephens reduced their price objective on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a research note on Friday, January 31st. Raymond James reaffirmed a “strong-buy” rating and issued a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Finally, StockNews.com raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, April 8th. Two analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $373.56.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.